Search clinical trials for: Analgesic consumption

Total 29039 results

Critical Therapeutics

Unknown

Study of Oral Zileuton in the Treatment of Moderate to Severe Facial Acne Vulgaris

Acne Vulgaris

United States
Radboud University Medical Center
Netherlands Brain Foundation; Netherlands Alzheimer Foundation; American Health...

Completed

Effect of Indomethacin on the Progression of Alzheimer's Disease

Alzheimer Disease

Netherlands
Icahn School of Medicine at Mount Sinai
Allergan

Completed

BOTOX® Versus Zanaflex® for the Treatment of Post-Stroke or Traumatic Brain Injury Upper Limb Spasticity

Upper Limb Spasticity
Odense University Hospital

Completed

OXY-2: The Pharmacogenetics of Oxycodone Analgesia in Human Experimental Pain Models

Healthy

Denmark
Hospital de Clinicas de Porto Alegre

Unknown

Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients

Diabetes Mellitus | Microalbuminuria

Brazil
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine in the Treatment of Stress Urinary Incontinence.

Urinary Incontinence, Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms

Urinary Incontinence, Stress

France, Sweden, Netherlands, Spain, Germany, South Africa, Switzerland
Eli Lilly and Company

Completed

Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania

Bipolar Disorder

Hungary, Australia, Greece, Russian Federation
Eli Lilly and Company
Boehringer Ingelheim

Completed

Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence

Urinary Incontinence, Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence

Stress Urinary Incontinence

United States, Canada
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.

Urinary Incontinence, Stress

United States, Canada, United Kingdom
Eli Lilly and Company

Completed

Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence

Urinary Stress Incontinence

United States, Slovenia, United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary Incontinence

Urinary Stress Incontinence

United States, Netherlands
Eli Lilly and Company

Completed

A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder

Depressive Disorder

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain

Depressive Disorder, Major

Belgium, Germany, France, Slovakia, Czech Republic, Finland
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)

Urinary Incontinence, Stress

Brazil, Canada, France, Germany, Italy, Mexico, Puerto Rico, Spain
Eli Lilly and Company
Boehringer Ingelheim

Completed

Open Label Phase III Duloxetine Study for Stress Urinary Incontinence

Urinary Incontinence Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

Efficacy and Safety of Duloxetine

Urinary Stress Incontinence

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence

Urinary Stress Incontinence

United States
Eli Lilly and Company

Completed

Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials

Major Depressive Disorder

Spain
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence

Stress Urinary Incontinence

United States
BZL Biologics

Completed

Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2

Prostatic Neoplasms

United States
Innovative Medical

Completed

Ketorolac vs. Steroid in the Prevention of CME

Cataract

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis

Ankylosing Spondylitis

Belgium
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis

Ankylosing Spondylitis
Nuvo Research Inc.

Completed

Efficacy and Safety of Topical Diclofenac Combined With Oral Diclofenac in the Treatment of Knee Osteoarthritis

Osteoarthritis, Knee

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis
National Institute of Arthritis and Musculoskeletal...

Completed

Blocking Tumor Necrosis Factor in Ankylosing Spondylitis

Spondylitis, Ankylosing

United States
Pfizer

Completed

Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain.

Pain
Pfizer

Completed

To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.

Diabetic Neuropathy, Painful
Pfizer

Completed

To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

Seizure Disorder, Partial

Spain, France, Italy, Australia, United Kingdom, Germany, Belgium, Netherlands, Austria, Sweden, Finland, South Africa, Switzerland
Pfizer

Completed

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

Seizure Disorder, Partial

United States, Canada
Pfizer

Completed

To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

Epilepsy, Partial

United States, Germany
Institute of Child Health

Completed

Prediction of Childhood Epilepsy Outcome in Bangladesh

Epilepsy

United Kingdom, Bangladesh
Pfizer

Completed

To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia.

Neuralgia
German Research Foundation

Terminated

Interpersonal Psychotherapy for Severely Depressed Inpatients

Major Depression

Germany
AlgoRx Pharmaceuticals

Completed

Efficacy and Safety of ALGRX 4975 in the Treatment of Postoperative Pain After Gall Bladder Removal

Postoperative Pain

Former Serbia and Montenegro
AlgoRx Pharmaceuticals

Completed

Efficacy and Safety of ALGRX 4975 in Treatment of Postoperative Pain After Hernia Repair

Postoperative Pain

Denmark
AlgoRx Pharmaceuticals

Completed

ALGRX 4975 After Total Knee Replacement

Knee Injuries | Arthroplasty, Replacement, Knee

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating MST-997 in Advanced Malignant Solid Tumors

Neoplasms

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating MST-997 in Advanced Malignant Solid Tumors

Neoplasms

United States
National Institute on Alcohol Abuse and Alcoholism...

Completed

Hangover, Congeners, Sleep and Occupational Performance

Neurobehavioral Manifestations | Sleep

United States
Pfizer

Completed

Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip

Osteoarthritis, Hip

United Kingdom
Merck Sharp & Dohme LLC

Terminated

A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome

Pain

France
Karlstad University

Completed

Study of Acupuncture and Care Interventions for the Treatment of Breast Inflammation During Breastfeeding

Mastitis

Sweden
CHU de Charleroi

Completed

The Effects of Clonidine on the Diuretic Response in Cirrhotic Patients

Ascitic Cirrhosis | Hyperactivation of Sympathetic Nervous System

Belgium
Novartis

Completed

Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout

Acute Gouty Arthritis

Germany, Switzerland
The George Institute
National Health and Medical Research Council, Australia; Medical Benefits Fund...

Completed

Prevention of Ectopic Bone Related Pain and Disability After Hip Replacement Surgery With Peri-Operative Ibuprofen

Arthritis, Rheumatoid | Osteoarthritis, Hip | Arthroplasty, Replacement, Hip
deCODE genetics
Duke University; Henry Ford Health System

Suspended

Veliflapon (DG-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina

Acute Coronary Syndrome

United States
University of Rochester
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Gabapentin Versus Estrogen for the Treatment of Hot Flashes

Hot Flashes

United States

Search clinical trials for: Analgesic consumption

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations